Effect of Etiasa on the expression of matrix metalloproteinase-2 and tumor necrosis factor-α in a rat model of ulcerative colitis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Medicine Reports

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/mmr.2012.1021PMID 22895819
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid Infliximab Infusions in Pediatric Inflammatory Bowel Disease

  2009cited by this paper
• Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.

  2007cited by this paper
• Expression of matrix metalloproteinase-1 and tumor necrosis factor-α in ulcerative colitis

  2007cited by this paper
• Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.

  2006cited by this paper
• The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis

  2003cited by this paper
• Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.

  2003cited by this paper
• Recent Developments in the Immunology of Inflammatory Bowel Disease

  2000cited by this paper
• 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.

  2000cited by this paper
• 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.

  2000cited by this paper
• Matrix metalloproteinase levels are elevated in inflammatory bowel disease.

  1999cited by this paper
• Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

  1998cited by this paper
• An orally administered growth factor extract derived from bovine whey suppresses breath ethane in colitic rats.

  1998cited by this paper
• A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

  1997cited by this paper
• A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

  1997cited by this paper
• Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat

  1996cited by this paper
• Cytokines in inflammatory bowel disease.

  1992cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

  1990cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

  1990cited by this paper

• Ozoile Reduces the LPS-Induced Inflammatory Response in Colonic Epithelial Cells and THP-1 Monocytes

  2023cites this paper
• In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis

  2021cites this paper
• Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation

  2020cites this paper
• Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway.

  2018cites this paper
• The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases

  2016cites this paper
• Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis

  2016cites this paper
• Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease.

  2015cites this paper
• Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update

  2015cites this paper
• Effect of curcumin on p38MAPK expression in DSS-induced murine ulcerative colitis.

  2015cites this paper